Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Valenti

Showing results (161-170 of 439) with videos related to

Pageof 44
Sort By:
Hepatology (Baltimore, Md.)|July 22, 2010
I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver diseaseLuca Valenti, Anna Alisi, Enrico Galmozzi, et al.
BMC Gastroenterology|September 10, 2010
Lack of association between peroxisome proliferator-activated receptors alpha and gamma2 polymorphisms and progressive liver damage in patients with non-alcoholic fatty liver disease: a case control studyPaola Dongiovanni, Raffaela Rametta, Anna Ludovica Fracanzani, et al.
World Journal of Gastroenterology|June 22, 2012
Patatin-like phospholipase domain containing-3 gene I148M polymorphism, steatosis, and liver damage in hereditary hemochromatosisLuca Valenti, Paolo Maggioni, Alberto Piperno, et al.
Metabolism: Clinical and Experimental|May 4, 2019
Association between Helicobacter pylori infection and risk of nonalcoholic fatty liver disease: An updated meta-analysisAlessandro Mantovani, Teresa Turino, Anna Altomari, et al.
Journal of Hepatology|August 14, 2012
Effect of the A736V TMPRSS6 polymorphism on the penetrance and clinical expression of hereditary hemochromatosisLuca Valenti, Anna Ludovica Fracanzani, Raffaela Rametta, et al.
European Journal of Clinical Investigation|May 16, 2014
Hepatic steatosis and PNPLA3 I148M variant are associated with serum Fetuin-A independently of insulin resistanceRaffaela Rametta, Massimiliano Ruscica, Paola Dongiovanni, et al.
Atherosclerosis|November 28, 2017
Subclinical cerebrovascular disease in NAFLD without overt risk factors for atherosclerosisLorena Airaghi, Mario Rango, Diletta Maira, et al.
Journal of Hepatology|August 27, 2010
Beta-globin mutations are associated with parenchymal siderosis and fibrosis in patients with non-alcoholic fatty liver diseaseLuca Valenti, Elena Canavesi, Enrico Galmozzi, et al.
Diabetes|March 5, 2008
Increased expression and activity of the transcription factor FOXO1 in nonalcoholic steatohepatitisLuca Valenti, Raffaela Rametta, Paola Dongiovanni, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 6, 2021
A Polygenic Risk Score to Refine Risk Stratification and Prediction for Severe Liver Disease by Clinical Fibrosis ScoresAntonio De Vincentis, Federica Tavaglione, Oveis Jamialahmadi, et al.
Pageof 44

Showing results (161-170 of 439) with videos related to

Sort By:
Pageof 44
Hepatology (Baltimore, Md.)|July 22, 2010
I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver diseaseLuca Valenti, Anna Alisi, Enrico Galmozzi, et al.
BMC Gastroenterology|September 10, 2010
Lack of association between peroxisome proliferator-activated receptors alpha and gamma2 polymorphisms and progressive liver damage in patients with non-alcoholic fatty liver disease: a case control studyPaola Dongiovanni, Raffaela Rametta, Anna Ludovica Fracanzani, et al.
World Journal of Gastroenterology|June 22, 2012
Patatin-like phospholipase domain containing-3 gene I148M polymorphism, steatosis, and liver damage in hereditary hemochromatosisLuca Valenti, Paolo Maggioni, Alberto Piperno, et al.
Metabolism: Clinical and Experimental|May 4, 2019
Association between Helicobacter pylori infection and risk of nonalcoholic fatty liver disease: An updated meta-analysisAlessandro Mantovani, Teresa Turino, Anna Altomari, et al.
Journal of Hepatology|August 14, 2012
Effect of the A736V TMPRSS6 polymorphism on the penetrance and clinical expression of hereditary hemochromatosisLuca Valenti, Anna Ludovica Fracanzani, Raffaela Rametta, et al.
European Journal of Clinical Investigation|May 16, 2014
Hepatic steatosis and PNPLA3 I148M variant are associated with serum Fetuin-A independently of insulin resistanceRaffaela Rametta, Massimiliano Ruscica, Paola Dongiovanni, et al.
Atherosclerosis|November 28, 2017
Subclinical cerebrovascular disease in NAFLD without overt risk factors for atherosclerosisLorena Airaghi, Mario Rango, Diletta Maira, et al.
Journal of Hepatology|August 27, 2010
Beta-globin mutations are associated with parenchymal siderosis and fibrosis in patients with non-alcoholic fatty liver diseaseLuca Valenti, Elena Canavesi, Enrico Galmozzi, et al.
Diabetes|March 5, 2008
Increased expression and activity of the transcription factor FOXO1 in nonalcoholic steatohepatitisLuca Valenti, Raffaela Rametta, Paola Dongiovanni, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 6, 2021
A Polygenic Risk Score to Refine Risk Stratification and Prediction for Severe Liver Disease by Clinical Fibrosis ScoresAntonio De Vincentis, Federica Tavaglione, Oveis Jamialahmadi, et al.
Pageof 44